Lista de obras -

A review of pulmonary arterial hypertension: role of ambrisentan

artículo científico publicado en 2007

ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American Coll

artículo científico publicado en 2009

ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American Co

artículo científico publicado en 2009

An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry ⬇️

artículo científico publicado el 1 de agosto de 2012

Analysis of the lung allocation score estimation of risk of death in patients with pulmonary arterial hypertension using data from the REVEAL Registry

artículo científico publicado en 2010

Bloodstream Infections in Patients With Pulmonary Arterial Hypertension Treated With Intravenous Prostanoids: Insights From the REVEAL REGISTRY® ⬇️

artículo científico publicado el 9 de agosto de 2012

Bloodstream infections in patients given treatment with intravenous prostanoids

artículo científico publicado en 2008

Clinical Perspectives with Long‐Term Pulsed Inhaled Nitric Oxide for the Treatment of Pulmonary Arterial Hypertension ⬇️

artículo científico publicado el 1 de abril de 2012

Clinical features of paediatric pulmonary hypertension: a registry study ⬇️

artículo científico publicado el 11 de enero de 2012

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

artículo científico publicado en 2002

Determinants of right ventricular ejection fraction in pulmonary arterial hypertension

artículo científico publicado en 2008

Diagnosis and differential assessment of pulmonary arterial hypertension

artículo científico publicado en 2004

Doppler-defined pulmonary hypertension and the risk of death in children with sickle cell disease followed for a mean of three years

artículo científico publicado en 2009

Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom

artículo científico publicado en 2011

Effect of imatinib as add-on therapy on echocardiographic measures of right ventricular function in patients with significant pulmonary arterial hypertension

artículo científico publicado en 2014

Eisenmenger's syndrome: current management

artículo científico publicado en 2002

Endothelin receptor antagonists in pulmonary arterial hypertension.

artículo científico publicado en 2004

Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies

artículo científico publicado en 2010

From short-term benefits to long-term outcomes: the evolution of clinical trials in pulmonary arterial hypertension

artículo científico publicado en 2013

Future perspectives for the treatment of pulmonary arterial hypertension

artículo científico publicado en 2009

Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension

artículo científico publicado en 2013

Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology

scientific article published on 01 December 2004

Hospitalization and survival in patients using epoprostenol for injection in the PROSPECT observational study

artículo científico publicado en 2015

Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity

artículo científico publicado en 2011

Idiopathic pulmonary arterial hypertension in children.

artículo científico publicado en 2005

Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy.

artículo científico publicado en 2010

Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study.

artículo científico publicado en 2013

Long-Term Outcomes in Children With Pulmonary Arterial Hypertension Treated With Bosentan in Real-World Clinical Settings ⬇️

artículo científico publicado el 1 de noviembre de 2010

Long-term sildenafil added to intravenous epoprostenol in patients with pulmonary arterial hypertension

artículo científico publicado en 2014

New trial designs and potential therapies for pulmonary artery hypertension

artículo científico publicado en 2013

PDGF signaling in pulmonary arterial hypertension

artículo científico publicado en 2005

Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society

artículo científico publicado en 2015

Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE-1 study.

artículo científico publicado en 2009

Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension

artículo científico publicado en 2003

Prostanoid therapy for pulmonary arterial hypertension.

artículo científico publicado en 2004

Repair of congenital heart disease with associated pulmonary hypertension in children: what are the minimal investigative procedures? Consensus statement from the Congenital Heart Disease and Pediatric Task Forces, Pulmonary Vascular Research [...]

artículo científico publicado en 2014

Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom

artículo científico publicado en 2014

Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease

artículo científico publicado en 2007

Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertension

artículo científico publicado en 2005

Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension

artículo científico publicado en 2008

Sildenafil citrate therapy for pulmonary arterial hypertension

artículo científico publicado en 2005

Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension

artículo científico publicado en 2005

Sitaxsentan therapy for pulmonary arterial hypertension

artículo científico publicado en 2003

Sitaxsentan: a novel endothelin-A receptor antagonist for pulmonary arterial hypertension

artículo científico publicado en 2005

Strategic plan for pediatric respiratory diseases research: an NHLBI working group report

artículo científico publicado en 2009

Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management

artículo científico publicado en 2011

The clinician as investigator: participating in clinical trials in the practice setting

artículo científico publicado en 2004

The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design

artículo científico publicado en 2004

The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis

artículo científico publicado en 2004

Treprostinil therapy for pulmonary artery hypertension

artículo científico publicado en 2002

Validation of two predictive models for survival in pulmonary arterial hypertension.

artículo científico publicado en 2015

Lista de obras de

A review of pulmonary arterial hypertension: role of ambrisentan

ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American Coll

ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American Co

An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry ⬇️

Analysis of the lung allocation score estimation of risk of death in patients with pulmonary arterial hypertension using data from the REVEAL Registry

Bloodstream Infections in Patients With Pulmonary Arterial Hypertension Treated With Intravenous Prostanoids: Insights From the REVEAL REGISTRY® ⬇️

Bloodstream infections in patients given treatment with intravenous prostanoids

Clinical Perspectives with Long‐Term Pulsed Inhaled Nitric Oxide for the Treatment of Pulmonary Arterial Hypertension ⬇️

Clinical features of paediatric pulmonary hypertension: a registry study ⬇️

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

Determinants of right ventricular ejection fraction in pulmonary arterial hypertension

Diagnosis and differential assessment of pulmonary arterial hypertension

Doppler-defined pulmonary hypertension and the risk of death in children with sickle cell disease followed for a mean of three years

Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom

Effect of imatinib as add-on therapy on echocardiographic measures of right ventricular function in patients with significant pulmonary arterial hypertension

Eisenmenger's syndrome: current management

Endothelin receptor antagonists in pulmonary arterial hypertension.

Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies

From short-term benefits to long-term outcomes: the evolution of clinical trials in pulmonary arterial hypertension

Future perspectives for the treatment of pulmonary arterial hypertension

Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension

Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology

Hospitalization and survival in patients using epoprostenol for injection in the PROSPECT observational study

Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity

Idiopathic pulmonary arterial hypertension in children.

Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy.

Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study.

Long-Term Outcomes in Children With Pulmonary Arterial Hypertension Treated With Bosentan in Real-World Clinical Settings ⬇️

Long-term sildenafil added to intravenous epoprostenol in patients with pulmonary arterial hypertension

New trial designs and potential therapies for pulmonary artery hypertension

PDGF signaling in pulmonary arterial hypertension

Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society

Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE-1 study.

Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension

Prostanoid therapy for pulmonary arterial hypertension.

Repair of congenital heart disease with associated pulmonary hypertension in children: what are the minimal investigative procedures? Consensus statement from the Congenital Heart Disease and Pediatric Task Forces, Pulmonary Vascular Research [...]

Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom

Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease

Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertension

Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension

Sildenafil citrate therapy for pulmonary arterial hypertension

Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension

Sitaxsentan therapy for pulmonary arterial hypertension

Sitaxsentan: a novel endothelin-A receptor antagonist for pulmonary arterial hypertension

Strategic plan for pediatric respiratory diseases research: an NHLBI working group report

Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management

The clinician as investigator: participating in clinical trials in the practice setting

The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design

The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis

Treprostinil therapy for pulmonary artery hypertension

Validation of two predictive models for survival in pulmonary arterial hypertension.